By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cordis Corporation 

14201 N.W. 60th Avenue

Miami  Florida  33014  U.S.A.
Phone: 800-327-7714 Fax: 610-889-4410


SEARCH JOBS


Industry
Medical Device






Company News
Cordis Corporation (JNJ) Launches SABER™ PTA Dilatation Catheter Tocomplement Portfolio Of Peripheral Arterial Disease Treatments 7/1/2014 10:32:43 AM
Cordis Corporation (JNJ) Receives CE Mark For RENLANE™ Renal Denervation System To Treat Resistant Hypertension 2/21/2014 8:38:47 AM
TriReme Medical Inc. Signs Distribution Agreement With Cordis Corporation (JNJ) 2/19/2014 7:11:45 AM
Cordis Corporation (JNJ) Release: Two-Year Data From INNOVATION Trial On INCRAFT® AAA Stent Graft System Continues To Demonstrate Safety And Performance In Treatment Of Abdominal Aortic Aneurysms 1/28/2014 9:44:35 AM
Johnson & Johnson (JNJ)'s Cordis Corporation (JNJ) Escapes $482 Million Verdict As Court Rejects Patent Appeal 1/27/2014 9:01:38 AM
Cordis Corporation (JNJ) Release: Three-Year Clinical Outcomes From Stroll Trial Demonstrate Sustained Durability And Performance Of S.M.A.R.T.® Stent For Treatment Of Peripheral Artery Disease 1/22/2014 9:20:23 AM
Federal Circuit Denies Re-Hearing for Cordis Corporation (JNJ) Patent Claims Against Medtronic, Inc. (MDT), Abbott Laboratories (ABT), Boston Scientific Corporation (BSX) 10/16/2013 7:32:40 AM
Cordis Corporation (JNJ) Release: Three-Year Data Demonstrates Sustained Improvements in Health Related Quality of Life in Patients with Superficial Femoral Artery Disease Treated With the S.M.A.R.T.® Stent 10/9/2013 11:17:15 AM
Medinol Ltd. Goes After Johnson & Johnson (JNJ)'s Cordis Corporation (JNJ) in Stent Patent War 8/28/2013 7:55:07 AM
Class 1 Recall Issued to Cordis Corporation (JNJ)'s Optease Retrievable Inferior Vena Cava (IVC) Filter 8/8/2013 8:40:48 AM
12345678910...
//-->